NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $242,000 | -51.7% | 1,090 | -71.2% | 0.02% | -54.8% |
| Q1 2021 | $501,000 | -23.6% | 3,790 | 0.0% | 0.04% | -28.8% |
| Q4 2020 | $656,000 | +55.5% | 3,790 | 0.0% | 0.06% | +37.2% |
| Q3 2020 | $422,000 | +87.6% | 3,790 | 0.0% | 0.04% | +72.0% |
| Q2 2020 | $225,000 | -33.6% | 3,790 | -24.8% | 0.02% | -44.4% |
| Q1 2020 | $339,000 | +7.3% | 5,040 | +34.4% | 0.04% | +25.0% |
| Q4 2019 | $316,000 | +12.9% | 3,750 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $280,000 | +2.9% | 3,750 | -12.8% | 0.04% | 0.0% |
| Q2 2019 | $272,000 | +31.4% | 4,300 | 0.0% | 0.04% | +24.1% |
| Q1 2019 | $207,000 | -21.0% | 4,300 | -14.0% | 0.03% | -25.6% |
| Q3 2018 | $262,000 | – | 5,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |